Axovant Sciences

Small-Cap Snapshot: Axovant reaches agreement to develop Parkinson's disease gene therapy

NCI Building Systems, Ambarella and Shiloh Industries are also making noise.

Axovant Sciences entered into a licensing agreement with London-based Oxford BioMedica

Axovant Sciences Ltd (NASDAQ:AXON) shares more than doubled after the clinical-stage biopharma entered into a licensing agreement with Oxford BioMedica plc (LSE:OXB) to develop and commercialize Oxford's gene therapy for Parkinson's disease. Axovant plans to initiate a Phase I/II dose escalation study of the drug known as AXO-Lenti-PD in patients with advanced Parkinson's disease by the end of 2018. Shares of the London-based company surged nearly 140% to US$4.14.

Metal product manufacturer NCI Building Systems Inc (NYSE:NCS) saw its shares rise after reporting an earnings beat and sales growth in its fiscal second-quarter results. The company makes metal components like panels and coatings for nonresidential buildings. NCI reported earnings of US$0.25 per share, beating Wall Street estimates by US$0.07. Sales rose nearly 9% to US$457.1mln compared with US$420.5mln in the previous year's second quarter. Shares of the Houston-based company jumped more than 8% to US$21.02.

READ: Axovant shares jump after welcoming former Allergan and Teva execs to its management team

Semiconductor manufacturer Ambarella Inc (NASDAQ:AMBA) reported an earnings and revenue beat in its fiscal first quarter but its shares fell on weak guidance going forward. The California-based company adjusted reported earnings of US$0.13 per share on revenue of US$56.69mln versus Wall Street estimates of US$0.09 per share on revenue of US$56.1mln. Ambarella expects revenue between US$60mln and US$64mln, falling below analyst estimates of US$68.2mln. The manufacturer supplies camera components to GoPro Inc (NASDAQ:GPRO). Shares were down more than 13% to US$42.81.

Automotive supply company Shiloh Industries Inc (NASDAQ:SHLO) beat on revenue in its fiscal second quarter but missed on earnings, sending its shares falling. The company reported earnings of US$0.24 per share on revenue of US$297.3mln versus analyst estimates of US$0.26 per share on revenue of US$269.5mln. Shiloh specializes in providing lightweighting and noise-reduction technologies to the mobility market. Shares of the Ohio-based company fell more than 9% to US$9.56.


Quick facts: Axovant Sciences

Price: £0.00

Market: NASDAQ
Market Cap: £0.00

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Phunware to launch Initial Exchange Offering for its Phun...

Phunware Inc (NASDAQ:PHUN) CEO Randall Crowder tells Proactive the tech company is launching an Initial Exchange Offering for its own new currency called Phun tokens, and explains the difference between this and an Initial Coin Offering. Crowder says the company hasn't raised funds since...

23 minutes ago

2 min read